Physician profile
Tarek Sayed
NPI 1174053870
$11,141.22
in general payments reported to CMS, 2019-2025
24 companies · $5,299 in 2025
The $5,299 reported for 2025 was more than what 94% of Foot & Ankle Surgery providers received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,750 · 2020: $894 · 2021: $306 · 2022: $690 · 2023: $417 · 2024: $1,785 · 2025: $5,299.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $4,146 · Food and Beverage: $3,355.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $4,145.68 |
| Food and Beverage | $3,355.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Convatec INC. | $3,064.66 | 2023-2025 | |
| Stryker Corporation | $2,365.86 | 2019-2025 | Citrefix, Prostep Mica, Augment Injectable |
| Treace Medical Concepts, INC. | $1,048.22 | 2025 | |
| Wright Medical Technology, INC. | $983.64 | 2019-2020 | |
| Eclipse Technology Solutions INC. | $731.10 | 2024 | |
| Paratek Pharmaceuticals, INC. | $549.61 | 2023-2025 | Nuzyra |
| Kerecis Limited | $435.34 | 2024-2025 | Kerecis Surgiclose, Kerecis Graftguide, Kerecis Omega3 Marigen |
| Smith+Nephew, INC. | $274.20 | 2021-2025 | Collagenase Santyl |
| Averitas Pharma INC. | $255.86 | 2024-2025 | Qutenza |
| Musculoskeletal Transplant Foundation INC. | $245.97 | 2020-2021 | |
| Zimmer Biomet Holdings, INC. | $213.67 | 2022 | |
| Arthrex, INC. | $204.95 | 2024 | |
| Organogenesis INC. | $172.32 | 2019-2025 | Via Matrix |
| Kuros Biosciences USA, INC | $159.00 | 2025 | Magnetos |
| Integra Lifesciences Corporation | $149.76 | 2019-2021 |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $59.49 | 2021-2022 | |
| Abbott Laboratories | $56.91 | 2021-2022 | |
| Next Science LLC | $50.70 | 2022-2025 | Blastx, Xperience |
| Vertex Pharmaceuticals Incorporated | $21.94 | 2024 | |
| Grt US Holding, INC. | $21.17 | 2021 | |
| Orthofix Medical, INC. | $21.11 | 2025 | Physio-Stim |
| Resmed Corp | $19.93 | 2023 | |
| Kci USA, INC. | $19.89 | 2023 | Promogran Prisma, Activ.A.C., V.A.C. Dermatac |
| Paragon 28, INC. | $15.92 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Tarek Sayed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.